Search
for
Sort by
Research 151–180 of 172
- Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
- Lupus erythematosus tumidus (LET) with autoimmune thyroid dysfunction (AITD) as the first presentation of systemic lupus erythematosus: A case report and review of the literature
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- The influence of interferon on healthy and diseased skin
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Dermatological manifestations of COVID-19 and its therapies: a review
- TONGUE, RED
- Chilblains in Turkey: a case-control study
- Nail Changes in Chilblains Mimicking Lichen Planus
- 220 Dynamic and spatial transcriptional responses in COVID-19-related chilblains
- Manifestasi Klinis COVID-19 Pada Kulit
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin
- Issue Information
- Characterization of novel TMEM173 mutation with additive IFIH1 risk allele
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- A case of chronic kidney disease patient with rapid deterioration of renal function, hair loss, and spontaneous resolution of facial warts after COVID‐19 infection
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- New‐onset and exacerbated skin diseases after COVID‐19 infection: A systematic review
- Antihypertensive Agents in Dermatology
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Cutaneous signs in COVID ‐19 patients: A review
- COVID-19感染症でみられる皮膚病変
- Dermatological Manifestations of COVID-19 Patients
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries